Published in TB and Outbreaks Week, August 20th, 2002
The phase I grant, in the amount of $268,000, will support the company's infectious disease research program to identify specific inhibitors of bacterial RNA polymerase, a critical enzyme responsible for gene transcription.
The project is a collaborative effort of Provid and Dr. Richard H. Ebright, Howard Hughes Medical Institute investigator and Rutgers University professor, an expert in RNA polymerase genomics and structural biology. The research plan supported by the grant is to design small molecule...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week